We create unique mergers and acquisitions portfolios to meet our global investors investment strategies and asset allocation needs. Our M&A strategy focuses on identifying high-growth companies within the life sciences, biotech, healthcare, diagnostics, and medical device sectors. Aligned with our commitment to market leadership and sustainability, we aim to create long-term value through strategic acquisitions